相关实验视频
Updated: Jul 5, 2026

09:25
Live Imaging of Mitosis in the Developing Mouse Embryonic Cortex
Published on: June 4, 2014
16.0K
在STRADA相关的大脑中通过mTOR过活性的延迟前脑刺激和抑制神经发生
Tong Pan1, Grace Lin1, Xuan Li2
1Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI, USA.
Stem cell reports
|March 6, 2026
概括
通过过度激活mTOR通路,STRADA基因变异会导致大脑发育问题. 在干细胞衍生的脑器官中抑制mTOR可以挽救这些发育问题,这表明对STRADA缺陷的潜在治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 遗传学 遗传学 是一个
背景情况:
- 在STRADA (与STE20相关的适配器α) 中的双致病变体导致大脑,和智力障碍.
- 斯特拉达是拉巴胺素 (mTOR) 途径机械标的上游调节者,对细胞生长和发育至关重要.
研究的目的:
- 为了研究mTOR通路的过度活性如何影响背部和腹部前脑发育中的细胞命运规范.
- 用STRADA淘汰人类干细胞衍生的脑器官作为模型系统.
主要方法:
- 产生STRADA淘汰赛人类干细胞衍生的大脑器官.
- 分析神经发生,原始细胞的增殖和细胞命运在背部和腹部前脑区域.
- 使用拉帕米辛的mTOR途径的药理抑制.
主要成果:
- 斯特拉达淘汰器官体表现出延迟的神经发生,增加了祖先的增殖,并在背部和腹部前脑中扩大了外部辐射质细胞群.
- 在腹前脑器官中观察到向增加的神经Y表达内部神经元的转变.
- 拉巴胺治疗挽救了大多数观察到的表型异常.
结论:
- 由于STRADA变异的原因,mTOR途径的过度活跃会导致内部神经元的产生和细胞命运的改变,这可能解释大脑,和认知障碍.
- 在胎儿大脑发育过程中,mTOR抑制为STRADA缺乏症提供了潜在的治疗策略.
关键词:
在PMSE综合征.在街道上.大脑是一个有机体的器官.细胞命运规范 细胞命运规范是一种.内部神经元的发展.在mTOROR中使用mTOR.在 mTORC1 的情况下,mTORC1 是 mTORC1.拉帕米的哺乳动物标是拉帕米.拉帕米的机械性标更多相关视频
相关概念视频
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

